Combined effects of lapatinib and bortezomib in human epidermal receptor 2 (HER2)-overexpressing breast cancer cells and activity of bortezomib against lapatinib-resistant breast cancer cells

Published 2010 View Full Article

Authors

Keywords

Journal

CANCER SCIENCE

Volume 101, Issue 10, Pages 2220-2226

Publisher

Wiley

Online

2010-07-07

DOI

10.1111/j.1349-7006.2010.01662.x

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

CANCER SCIENCE

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Find Funding. Review Successful Grants.

Find the ideal target journal for your manuscript